, and aggressiveness e.g., non-progressive vs malignant/metastatic) ( 41 , 42 ) and have demonstrable predictive utility at a tissue level ( 43 ). More recently, blood-based assays (CTCs, miRNA and circulating mRNA) have been developed. The most
Kjell Oberg, Eric Krenning, Anders Sundin, Lisa Bodei, Mark Kidd, Margot Tesselaar, Valentina Ambrosini, Richard P Baum, Matthew Kulke, Marianne Pavel, Jaroslaw Cwikla, Ignat Drozdov, Massimo Falconi, Nicola Fazio, Andrea Frilling, Robert Jensen, Klaus Koopmans, Tiny Korse, Dik Kwekkeboom, Helmut Maecke, Giovanni Paganelli, Ramon Salazar, Stefano Severi, Jonathan Strosberg, Vikas Prasad, Aldo Scarpa, Ashley Grossman, Annemeik Walenkamp, Mauro Cives, Irene Virgolini, Andreas Kjaer and Irvin M Modlin
Emma Jernberg, Anders Bergh and Pernilla Wikström
in clinical samples and experimental systems and thereby to sensitising tumour epithelial cells to low androgen levels ( 23 , 24 ). Detection of AR amplification in circulating tumour cells (CTCs) and circulating tumour DNA (ctDNA) isolated from
Anastasia K Armeni, Konstantinos Assimakopoulos, Dimitra Marioli, Vassiliki Koika, Euthychia Michaelidou, Niki Mourtzi, Gregoris Iconomou and Neoklis A Georgopoulos
polymorphism was conducted using restriction enzyme PvuII following gel agarose electrophoresis. Study of rs53576(G→A) polymorphism of oxytocin receptor gene ( OXTR ) was conducted using PCR method. The primers were F: 5′-GCC CAC CAT GCT CTC CAC ATC-3′ και R
Natalio García-Honduvilla, Alberto Cifuentes, Miguel A Ortega, Marta Pastor, Garazi Gainza, Eusebio Gainza, Julia Buján and Melchor Álvarez-Mon
′→3′) Temp. (°C) Amp. size (bp) GAPDH FwdRev TGA ACG GGA AGC TCA CTG GTCC ACC ACC CTG TTG CTG TA 60 306 IL-2 FwdRev CTG ACG CTT GTC CTC CTT GTCTGC TGC TGT GTT TCC TTT GC 60 64 IL-10 FwdRev CAT GGC CCA GAA ATC AAG
Wioletta Pijacka, Morag G Hunter, Fiona Broughton Pipkin and Martin R Luck
GTT GT REN L43524 GAC CGA GGA CGT CTT CTC C 378 62 CTT GGA GGC AAA GCC TAC AC ACE TC255148 TCT CGC TGC TGA GAA GAT CA 359 60 CAT TCG GGT CAG GAA GTT GT AGTR1 NM_174233 CAT TAC GAA TCC CAA AAT TCT ACC 344 60 AGG CAA TTG TTA AAA TAA GCC AAG AGTR2 NM
Elizaveta Mamedova, Natalya Mokrysheva, Evgeny Vasilyev, Vasily Petrov, Ekaterina Pigarova, Sergey Kuznetsov, Nikolay Kuznetsov, Liudmila Rozhinskaya, Galina Melnichenko, Ivan Dedov and Anatoly Tiulpakov
, 5′-GGG GCG GGT GGA ACC TTA G-3′; 2F, 5′-TTG GGT CAC AGG CTT GGA AAG-3′; 3R, ACA GGG ACC ACC CAC CAT GTG-3′; 8F, 5′-AAG AAT GTT CCC AAC CTA TGC-3′; 9R, 5′-GCA GAA CAT GGG CTC AGA GTT G-3′. Next-generation sequencing (NGS) NGS was performed in
Soraya Puglisi, Paola Perotti, Mattia Barbot, Paolo Cosio, Carla Scaroni, Antonio Stigliano, Pina Lardo, Valentina Morelli, Elisa Polledri, Iacopo Chiodini, Giuseppe Reimondo, Anna Pia and Massimo Terzolo
interventions: the TREND statement . American Public Health Association 2004 94 361 – 366 . ( https://doi.org/10.2105/AJPH.94.3.361 ) 10.2105/AJPH.94.3.361 11 Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 . (available from: http://ctep.cancer.gov/reporting/ctc
Marra Jai Aghajani, Tara Laurine Roberts, Tao Yang, Charles Eugenio McCafferty, Nicole J Caixeiro, Paul DeSouza and Navin Niles
reported. Funding This research was funded by the Ingham Institute for Applied Medical Research CTC Head & Neck Research Grant. T L R is the recipient of a Cancer Institute New South Wales Future Research Leader Fellowship. M J A is the recipient of
Maurício Martins da Silva, Lueni Lopes Felix Xavier, Carlos Frederico Lima Gonçalves, Ana Paula Santos-Silva, Francisca Diana Paiva-Melo, Mariana Lopes de Freitas, Rodrigo Soares Fortunato, Leandro Miranda-Alves and Andrea Claudia Freitas Ferreira
′ Reverse 5′ TGA CAA GCC ACA GAA CTC TC 3′ β-Tsh Forward 5′ TCT GCG CTG GGT ATT GTA TG 3′ Reverse 5′ CGG TAT TTC CAC CGT TCT GT 3′ Gapdh Forward 5′ TGA TTC TAC CCA CGG GAA GT 3′ Reverse 5′ AGC ATC ACC CCA TTT GAT GT
